Literature DB >> 29337244

MiR-142-5p act as an oncogenic microRNA in colorectal cancer: Clinicopathological and functional insights.

Farhadul Islam1, Vinod Gopalan2, Jelena Vider3, Cu-Tai Lu4, Alfred K-Y Lam5.   

Abstract

OBJECTIVES: miR-142-5p was noted aberrantly expressed and plays important roles in different pathophysiological conditions in human. The present study aims to examine the expression of miR-142-5p and its association with clinicopathological factors in a large cohort of patients with colorectal cancer. In addition, the cellular effects of miR-142-5p and its interacting targets in colon cancer cells were investigated.
METHODS: Expression of miR-142-5p in colorectal cancer tissues (n=125) and colon cancer cell lines were analysed using real-time polymerase chain reaction. In vitro assays (cell proliferation, wound healing and colony formation) were used to study the miR-142-5p induced cellular effects. Western blots were used to examine the modulation of FAM134B, KRAS, EPAS1 and KLF6 proteins expression followed by miR-142-5p expression-manipulation.
RESULTS: Significant high expression of miR-142-5p was noted in cancer tissues and cells when compared to the controls (p<0.001). Overexpression of miR-142-5p in patients with colorectal cancer was common (72%; 90/125). miR-142-5p overexpression was associated with cancer in the proximal colorectum and with B-raf positive patients (p=0.05). Exogenous overexpression of miR-142-5p resulted in significantly increased cell proliferation, colony formation, and wound healing capacities, whereas inhibition of endogenous miR-142-5p led reduced cancer growth properties. The cellular effects of miR-142-5p were mediated by the modulation of tumour suppressor KLF6 expression, as the expression of miR-142-5p and KLF6 protein are inversely correlated in colon cancer cells.
CONCLUSION: High miR-142-5p expression was associated with the biological aggressiveness of cancer. Thus, suppression of miR-142-5p could be a therapeutic strategy for patients with colorectal cancers.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Colorectal cancer; KLF6; Onco-miRNA; Targeted therapy; miR-142-5p

Mesh:

Substances:

Year:  2018        PMID: 29337244     DOI: 10.1016/j.yexmp.2018.01.006

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  15 in total

Review 1.  Mesenchymal stem cell (MSC)-derived exosomes as novel vehicles for delivery of miRNAs in cancer therapy.

Authors:  Behnoush Sohrabi; Behnaz Dayeri; Elahe Zahedi; Shahrouz Khoshbakht; Najme Nezamabadi Pour; Hamta Ranjbar; Abolfazl Davari Nejad; Mahdi Noureddini; Behrang Alani
Journal:  Cancer Gene Ther       Date:  2022-01-26       Impact factor: 5.854

2.  Circular RNA TMEM87A promotes cell proliferation and metastasis of gastric cancer by elevating ULK1 via sponging miR-142-5p.

Authors:  Haixiao Wang; Guangli Sun; Penghui Xu; Jialun Lv; Xing Zhang; Lu Zhang; Sen Wang; Jiacheng Cao; Yiwen Xia; Zhe Xuan; Bowen Li; Xiaoxu Huang; Tianlu Jiang; Lang Fang; Zekuan Xu
Journal:  J Gastroenterol       Date:  2020-11-06       Impact factor: 7.527

3.  miRNA-6715-5p Inhibits Cellular Proliferation and Invasion in Colorectal Cancer by Directly Targeting CST4.

Authors:  Ding Shi; Zheng Zhou; Shun Zhang
Journal:  J Oncol       Date:  2021-05-29       Impact factor: 4.375

4.  Circular RNAs hsa_circ_0032462, hsa_circ_0028173, hsa_circ_0005909 are predicted to promote CADM1 expression by functioning as miRNAs sponge in human osteosarcoma.

Authors:  Gaoyang Chen; Qingyu Wang; Qiwei Yang; Zhaoyan Li; Zhenwu Du; Ming Ren; Haiyue Zhao; Yang Song; Guizhen Zhang
Journal:  PLoS One       Date:  2018-08-28       Impact factor: 3.240

5.  The genomic landscape of undifferentiated embryonal sarcoma of the liver is typified by C19MC structural rearrangement and overexpression combined with TP53 mutation or loss.

Authors:  Bhuvana A Setty; Goodwin G Jinesh; Michael Arnold; Fredrik Pettersson; Chia-Ho Cheng; Ling Cen; Sean J Yoder; Jamie K Teer; Elsa R Flores; Damon R Reed; Andrew S Brohl
Journal:  PLoS Genet       Date:  2020-04-20       Impact factor: 5.917

6.  miR‑3666 suppresses cellular proliferation and invasion in colorectal cancer by targeting SATB2.

Authors:  Daqing Yang; Rizeng Li; Jianfu Xia; Wencai Li; Hong Zhou
Journal:  Mol Med Rep       Date:  2018-10-09       Impact factor: 2.952

7.  Semen miRNAs Contained in Exosomes as Non-Invasive Biomarkers for Prostate Cancer Diagnosis.

Authors:  Maria Barceló; Manel Castells; Lluís Bassas; Francesc Vigués; Sara Larriba
Journal:  Sci Rep       Date:  2019-09-24       Impact factor: 4.379

8.  Downregulation of LUZP2 Is Correlated with Poor Prognosis of Low-Grade Glioma.

Authors:  Yong Li; Gang Deng; Yangzhi Qi; Huikai Zhang; Hongxiang Jiang; Rongxin Geng; Zhang Ye; Baohui Liu; Qianxue Chen
Journal:  Biomed Res Int       Date:  2020-07-09       Impact factor: 3.411

9.  Involvement of Differentially Expressed microRNAs in the PEGylated Liposome Encapsulated 188Rhenium-Mediated Suppression of Orthotopic Hypopharyngeal Tumor.

Authors:  Bing-Ze Lin; Shen-Ying Wan; Min-Ying Lin; Chih-Hsien Chang; Ting-Wen Chen; Muh-Hwa Yang; Yi-Jang Lee
Journal:  Molecules       Date:  2020-08-08       Impact factor: 4.411

10.  A novel homeostatic loop of sorcin drives paclitaxel-resistance and malignant progression via Smad4/ZEB1/miR-142-5p in human ovarian cancer.

Authors:  Jinguo Zhang; Wencai Guan; Xiaolin Xu; Fanchen Wang; Xin Li; Guoxiong Xu
Journal:  Oncogene       Date:  2021-06-23       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.